Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aborted exenterative procedures in recurrent cervical cancer

B Miller1, M Morris, F Rutledge

  • 1Department of Gynecologic Oncology, M. D. Anderson Cancer Center, University of Texas, Houston 77030.

Gynecologic Oncology
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are amyotrophic lateral sclerosis patients cognitively normal?

Neurology·2003
Same author

Radiation hybrid map, physical map, and low-pass genomic sequence of the canine prcd region on CFA9 and comparative mapping with the syntenic region on human chromosome 17.

Genomics·2003
Same author

Hypothalamic control of gonadotropin secretion.

Progress in brain research·2003
Same author

The behavioral spectrum of tic disorders: a community-based study.

Neurology·2002
Same author

Early retinal damage in experimental diabetes: electroretinographical and morphological observations.

Experimental eye research·2002
Same author

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.

Neurology·2002
Same journal

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Gynecologic oncology·2026
Same journal

Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

Gynecologic oncology·2026
Same journal

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same journal

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same journal

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same journal

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026
See all related articles

Advanced cervical cancer often leads to aborted pelvic exenteration. Preoperative factors like pelvic mass and short interval post-therapy can predict unresectability, necessitating improved diagnostic methods.

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology
  • Cancer Recurrence

Background:

  • Pelvic exenteration is a major surgery for recurrent cervical cancer.
  • Aborted procedures due to advanced disease are common and distressing.
  • Identifying preoperative predictors of unresectability is crucial.

Purpose of the Study:

  • To identify preoperative factors predicting unresectability in patients undergoing exploration for pelvic exenteration.
  • To analyze reasons for aborted pelvic exenteration procedures in recurrent cervical cancer.
  • To improve patient selection and reduce unnecessary surgical exploration.

Main Methods:

  • Retrospective review of 394 patients undergoing exploration for pelvic exenteration for recurrent cervical cancer (1970-1990).

Related Experiment Videos

  • Analysis of preoperative findings and pathological diagnoses.
  • Statistical correlation of preoperative factors with reasons for aborted procedures.

    • Main Results:

    • 111 of 394 patients (28%) had procedures aborted due to advanced disease.
    • Peritoneal disease (44%) was associated with pelvic mass (P=0.03).
    • Nodal disease (40%) correlated with short interval from primary therapy (P=0.008) and preoperative fibrosis (P=0.01).
    • Peritoneal cytology was often negative (77.2%) but valuable for adenocarcinoma.
    • Hepatic lesions or bowel involvement occurred in 4.5% of cases.

    Conclusions:

    • Disseminated disease is difficult to detect preoperatively.
    • Computed tomography, lymphangiography, fine-needle aspiration, and peritoneal cytology (for adenocarcinoma) are key for reducing aborted procedures.
    • Improved preoperative assessment is vital for optimizing surgical planning in recurrent cervical cancer.